Data / Medical devices / Canada / Luminex Molecular Diagnostics, Inc.
Luminex Molecular Diagnostics, Inc.: FDA-registered device maker in TORONTO Ontario, Canada, 18 510(k) clearances
Luminex Molecular Diagnostics, Inc. is registered with the FDA (registration 3002777243) in TORONTO Ontario, Canada. It lists 16 device types. The FDA files 18 510(k) clearances under its listings, the newest dated October 2, 2024. 3 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3002777243
- Address
- 439 University Ave., TORONTO Ontario, Canada, M5G 1Y8
- Owner or operator
- Luminex Corporation (9032042)
- Roles
- Manufacturer
- First device listed
- April 9, 2004
- Registered through
- 2026
- Brand names listed
- Gastrointestinal Pathogen Panel (GPP), NXTAG Respiratory Pathogen Panel, NxTAG Respiratory Pathogen Panel, NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2), NxTAG® Respiratory Pathogen Panel, TAG-IT, Xtag Cystic Fibrosis 39 Kit V2, Xtag Cystic Fibrosis 60 Kit V2 and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| October 2, 2024 | K242613 | NxTAG® Respiratory Pathogen Panel | OCC | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| March 11, 2024 | K231758 | NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2) | QOF | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| December 11, 2019 | K193167 | NxTAG Respiratory Pathogen Panel, NxTAG Respiratory Pathogen Panel Files, SYNCT Software | OCC | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| November 12, 2019 | K191161 | xTAG Gastrointestinal Pathogen Panel (GPP) | PCH | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| November 4, 2019 | K191160 | xTAG Gastrointestinal Pathogen Panel (GPP), xTAG Data Analysis Software (TDAS GPP) | PCH | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| November 30, 2018 | K183030 | xTAG Gastrointestinal Pathogen Panel (GPP), xTAG Data Analysis Software (TDAS GPP) | PCH | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| November 30, 2018 | K183023 | xTAG Gastrointestinal Pathogen Panel (GPP), xTAG Data Analysis Software (TDAS GPP) | PCH | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| December 15, 2016 | K163347 | xTAG Cystic Fibrosis 39 Kit v2 | NUA | Unknown | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| December 15, 2016 | K163336 | xTAG Cystic Fibrosis 60 Kit v2, xTAG Data Analysis Software (TDAS) CFTR | NUA | Unknown | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| December 17, 2015 | K152386 | NxTAG Respiratory Pathogen Panel, NxTAG Respiratory Pathogen Panel Files, SYNCT Software | OCC | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| October 24, 2014 | K140647 | XTAG GASTROINTESTINAL PATHOGEN PANEL(GPP)/XTAG DATA ANALYSIS SOFTWARE FOR GPP(TDAS GPP) | PCH | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| September 16, 2014 | K140377 | XTAG GASTROINTESTINAL PATHOGEN PANEL (GPP)/XTAG DATA ANALYSIS SOFTWARE FOR GPP (TDAS GPP) | PCH | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| September 11, 2013 | K131565 | XTAG CYP2C19 KIT V3 | NTI | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| March 21, 2013 | K121894 | XTAG GASTROINTESTINAL PATHOGEN PANEL(GPP) XTAG DATA ANALYSIS SOFTWARE FOR GPP (TDAS GPP) LUMINEX MAGPIX | PCH | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| January 14, 2013 | DEN130003 | XTAG GASTROINTESTINAL PATHOGEN PANEL (GPP) XTAG DATA ANALYSIS SOFTWARE FOR GPP (TDAS) | PCH | Unknown | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| December 11, 2009 | K083845 | XTAG CF60 KIT V2 | NUA | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| September 1, 2009 | K083846 | XTAG CYSTIC FIBROSIS 39 KIT V2, (CFTR 39 KIT V2), MODEL I027C0231, I027D0266, I027E0267 | NUA | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
| January 3, 2008 | DEN070013 | ID-TAG RESPIRATORY VIRAL PANEL | OCC | Unknown | Luminex Molecular Diagnostics, Inc. | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| September 5, 2024 | 95377 | Class II | Ongoing | NxTAG Respiratory Pathogen Panel, REF: I051C0447 | Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially result in hMPV false positives. | accessdata.fda.gov |
| July 16, 2019 | 83472 | Class II | Ongoing | xTAG Respiratory Viral Panel (RVP): Box Label: xTAG RVP (Respiratory Viral Panel). Catalogue Number:I019C0111 in vitro diagnostic test | The Assay may give a false negative result when detecting and subtyping Influenza A (H3) and detecting RSV A in patient specimens. However, the assay will continue to detect Influenza A, Influenza B, RSV B and all other targets in accordance with each of these products performance claims. | accessdata.fda.gov |
| February 22, 2019 | 82745 | Class II | Ongoing | xTAG Gastrointestinal Pathogen Panel intended for the simultaneous qualitative detection and identification of multiple viral, bacterial and parasitic nucleic acids in human stool specimens or human stool (GPP) Kit, IVD, | Reports have been received of lower MS2 MFI values when using the panel. | accessdata.fda.gov |
Compare with other makers
- All makers of Clinical Sample Concentrator
- All makers of Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
- All makers of Instrumentation For Clinical Multiplex Test Systems
- All makers of Influenza A Virus Subtype Differentiation Nucleic Acid Assay
- All makers of Non-Sars Coronavirus Multiplex Nucleic Acid Assay
- All makers of Respiratory Virus Panel Nucleic Acid Assay System
Updated October 9, 2024. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.